Previous 10 | Next 10 |
Dan Loeb's 13F portfolio value increased from ~$7.30B to ~$10B this quarter. The number of positions increased from 36 to 47. Third Point added PG&E while dropping Baxter International and Raytheon Technologies during the quarter. The top three positions are at ~22% of the por...
IQVIA™, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that Zentiva, a leading player in branded generic and OTC medications in the European and CIS markets, is leveraging IQVIA...
Image source: The Motley Fool. IQVIA Holdings Inc. (NYSE: IQV) Q3 2020 Earnings Call Oct 20, 2020 , 9:00 a.m. ET Operator Continue reading For further details see: IQVIA Holdings Inc. (IQV) Q3 2020 Earnings Call Transcript
IQVIA Holdings Inc. (IQV) Q3 2020 Earnings Conference Call October 20, 2020 9:00 a.m. ET Company Participants Andrew Markwick - SVP, IR, and Treasury Ari Bousbib - Chairman and CEO Ron Bruehlman - EVP and CFO Eric Sherbet - EVP and General Counsel Nick Childs - SVP, Financial Planning and Ana...
The following slide deck was published by IQVIA Holdings Inc. in conjunction with their 2020 Q3 earnings call. For further details see: IQVIA Holdings Inc. 2020 Q3 - Results - Earnings Call Presentation
IQVIA (IQV) Q3 results:Revenue: $2,786M (+0.6%).Net income: $101M (+77.2%); non-GAAP net income: $318M (flat); EPS: $0.52 (+79.3%); non-GAAP EPS: $1.63 (+1.9%); non-GAAP EBITDA: $604M (+1.9%).Cash flow ops (9 mo.): $1,209M (+45.0%).Q4 guidance: Revenue: $3,040M - 3,190M (+5.0 - 10.2%); non-GA...
IQVIA (IQV): Q3 Non-GAAP EPS of $1.63 beats by $0.09; GAAP EPS of $0.52 beats by $0.09.Revenue of $2.79B (+0.7% Y/Y) beats by $40M.Press Release For further details see: IQVIA EPS beats by $0.09, beats on revenue
IQVIA (NYSE:IQV) is scheduled to announce Q3 earnings results on Tuesday, October 20th, before market open.The consensus EPS Estimate is $1.52 (-5.0% Y/Y) and the consensus Revenue Estimate is $2.75B (-0.7% Y/Y).Over the last 2 years, IQV has beaten EPS estimates 100% of the time and has beat...
[[ACI]], [[CBSH]], [[CMA]], [[CP]], [[DOV]], [[GATX]], [[GPK]], [[IQV]], [[IRDM]], [[LMT]], [[MAN]], [[NVR]], [[PCAR]], [[PG]], [[PLD]], [[PM]], [[PNR]], [[RF]], [[SBNY]], [[SNV]], [[SYF]], [[TRV]], [[UBS]]For Seeking Alpha's full earnings season calendar, click here. For further details se...
IQVIA™ (NYSE: IQV), in scientific partnership with the U.S. Food and Drug Administration, will provide agile analytics from IQVIA’s CARE Project COVID-19 registry to support better understanding of how people in the community are affected by exposure to the coronavirus. IQ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...